Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1994 2
1995 2
1996 2
1997 1
1998 2
1999 3
2000 2
2001 2
2003 3
2004 2
2005 5
2006 3
2007 8
2008 14
2009 13
2010 21
2011 23
2012 13
2013 12
2014 7
2015 13
2016 9
2017 10
2018 9
2019 14
2020 8
2021 9
2022 2
2023 8
2024 5
2025 3
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

208 results

Results by year

Filters applied: . Clear all
Page 1
Clinical and molecular data to predict flares in DMARD optimization in rheumatoid arthritis: a randomized, controlled, open-label, non-inferiority trial.
Blanco FJ, Galindo L, Acasuso B, Balboa-Barreiro V, Cañete JD, Fernández-Gutiérrez B, González-Álvaro I, Pablos Álvarez JL, Bejerano-Herrería C, Silva-Díaz M, Rego-Perez I, Lourido L, Ruiz-Romero C, Uriarte-Ecenarro M, García-Vicuña R, Cuervo A, Ramírez J, Celis R, Rodríguez-Rodríguez L, Abasolo Alcázar L, Freites Nuñez D, Martín-López M, Toro-Santos FJ, Oreiro N. Blanco FJ, et al. Among authors: fernandez gutierrez b. Rheumatology (Oxford). 2026 Mar 5;65(3):keag050. doi: 10.1093/rheumatology/keag050. Rheumatology (Oxford). 2026. PMID: 41578952 Free PMC article. Clinical Trial.
Differential Expression of Galectin-1 and Galectin-9 in Immune-Mediated Inflammatory Diseases.
Valero-Martínez C, Pardines-Ortiz M, Montes N, Dauden E, Fernández-Gutierrez B, García-Planella E, Gomollón García F, Gratacós J, Pérez-Venegas JJ, Julía A, Marsal S, Lamana A, García-Vicuña R, González-Alvaro I, Triguero-Martínez A. Valero-Martínez C, et al. Among authors: fernandez gutierrez b. Int J Mol Sci. 2025 Sep 18;26(18):9087. doi: 10.3390/ijms26189087. Int J Mol Sci. 2025. PMID: 41009653 Free PMC article.
Primary non-response in inflammatory arthritis treated with biologics and targeted therapies in daily clinical practice.
Leon L, Freites-Nuñez D, Toledano E, Candelas G, Martinez C, Rodríguez-Laguna M, Fernández-Gutiérrez B, Abasolo L. Leon L, et al. Among authors: fernandez gutierrez b. Ther Adv Musculoskelet Dis. 2025 Mar 30;17:1759720X251325665. doi: 10.1177/1759720X251325665. eCollection 2025. Ther Adv Musculoskelet Dis. 2025. PMID: 40166776 Free PMC article.
The potential role of fatigue in difficult-to-treat rheumatoid arthritis.
Leon L, Freites-Núñez D, Madrid A, Rodriguez-Mariblanca M, Fernandez-Gutierrez B, Abasolo L. Leon L, et al. Among authors: fernandez gutierrez b. BMC Rheumatol. 2024 Sep 30;8(1):49. doi: 10.1186/s41927-024-00423-5. BMC Rheumatol. 2024. PMID: 39350299 Free PMC article.
Switching related to inefficacy in biologics and targeted synthetic therapies for psoriatic arthritis: a comparative real-life study.
Freites-Nuñez D, Leon L, Toledano E, Candelas G, Martinez C, Rodriguez-Laguna M, Rubio D, Fernandez-Gutierrez B, Abasolo L. Freites-Nuñez D, et al. Among authors: fernandez gutierrez b. Ther Adv Musculoskelet Dis. 2024 Aug 31;16:1759720X241273083. doi: 10.1177/1759720X241273083. eCollection 2024. Ther Adv Musculoskelet Dis. 2024. PMID: 39219744 Free PMC article.
208 results